This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Zywie Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Stephen Pasternak and His Ambroxol-Related Patent
Introduction
Stephen Pasternak is an inventor associated with London, Canada, and Zywie Inc. His work includes a patent concerning modified forms of ambroxol for therapeutic use.
Latest Patents
Pasternak is listed as an inventor on 1 patent: “Modified Forms of Ambroxol for Therapeutic Use.” The invention relates to analog forms of ambroxol and related compounds, compositions containing them, and methods of preventing or treating diseases and medical conditions through their administration.
Career Highlights
Pasternak’s listed patent reflects work in therapeutic compounds and potential medical applications. The available information identifies Zywie Inc. as the company with which he is associated.
Collaborations
The listed coworkers associated with Pasternak are Stephen Anderson and Vincent Jacques.
Conclusion
Stephen Pasternak’s patent focuses on modified ambroxol-related compounds and their potential therapeutic uses, highlighting his contribution to pharmaceutical innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile